Pharmacokinetic/ Pharmacodynamics in Drug Development and Evaluation of Efficacy (2/2)

By providing such information to clinicians, drug therapy

can achieve the goal of maximal therapeutic effect while

engendering the lowest probability of encountering a drug

exposure-related adverse event.

ISAP / FDA workshop, March 1st, 1999

http://www.isap.org/Rockville-1999.htm

Previous slide

Next slide

Back to first slide

View graphic version